Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Industry-Academia Cooperation Promotes Development, School-Enterprise Integration Cultivates New Opportunities
Release Time:
2020-06-18
６ 15th of the month On the day, led by Wang Bingming, Deputy County Governor of Weixian People's Government (seconded from the Ministry of Education), our company's Chairman Mao Jiang and a delegation of nine people visited Nankai University, Tianjin University, Hebei University of Technology, and Tianjin Vocational University for exchange and visits. They had in-depth discussions with representatives from relevant universities on establishing high-level industry-university-research cooperation relationships.
At the exchange meeting with Nankai University, our Chairman Mao Jiang introduced the achievements of the company's blood purification project in technology research and development, clinical application, and later-stage use. He focused on the plan to make significant investments to establish the "Nankai-Lijiang Blood Purification Research and Development Center" based on the existing industry-university-research cooperation with Nankai University. Director Li Wei of Nankai University's Research Office affirmed Lijiang Bio's achievements in the field of blood purification and expressed willingness to deepen horizontal cooperation between the university and the enterprise. He is willing to integrate Nankai University's strong research and development capabilities to strongly support Lijiang Bio's blood purification project and to establish a blood purification research and development base as soon as possible.
Keyword:
Recommended Reading
24-05-14 14:37:56
